Difference between revisions of "MEDICATION-ADENOSINE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 4: | Line 4: | ||
==Reference(s)== | ==Reference(s)== | ||
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council. | Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council. | ||
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons. | <br/>American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons. | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Revision as of 01:50, 17 December 2022
1. Depresses conduction through the AV node.
2. In paroxysmal SVT it can interrupt re-entry circuits involving AV nodes and restore normal sinus rhythm.
3. Indication: SVT.
SE
4. CVS: facial flushing, headache, hypotension, transient asystole.
5. Respiratory: dyspnoea, hyperventilation.
6. CNS: giddiness, blurring of vision.
7. GIT: metallic taste, tightness in the throat.
DOSAGE
8. 3mg - 6mg - 12mg boluses up to 2min apart.
Reference(s)
Gale, M., Grantham, H., Morley, P. and Parr, M. (2016). Advanced Life Support Level 1: 3rd Australian Edition. Australian Resuscitation Council.
American College Of Surgeons. Committee On Trauma (2012). ATLS : student course manual. Chicago, Ill.: American College Of Surgeons.
